CARL ZEISS MEDITEC AG - BR (AFX.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:AFX - DE0005313704 - Common Stock
28.6 EUR
-0.74 (-2.52%)
AFX gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 67 industry peers in the Health Care Equipment & Supplies industry. While AFX has a great health rating, its profitability is only average at the moment. AFX may be a bit undervalued, certainly considering the very reasonable score on growth
1. Profitability
1.1 Basic Checks
- AFX had positive earnings in the past year.
- AFX had a positive operating cash flow in the past year.
- In the past 5 years AFX has always been profitable.
- AFX had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- The Return On Assets of AFX (4.15%) is comparable to the rest of the industry.
- AFX has a Return On Equity of 6.67%. This is comparable to the rest of the industry: AFX outperforms 50.75% of its industry peers.
- AFX's Return On Invested Capital of 5.79% is in line compared to the rest of the industry. AFX outperforms 52.24% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for AFX is below the industry average of 9.84%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.15% | ||
| ROE | 6.67% | ||
| ROIC | 5.79% |
ROA(3y)6.33%
ROA(5y)7.85%
ROE(3y)9.62%
ROE(5y)11.54%
ROIC(3y)7.11%
ROIC(5y)9.66%
1.3 Margins
- With a Profit Margin value of 6.34%, AFX perfoms like the industry average, outperforming 52.24% of the companies in the same industry.
- AFX's Profit Margin has declined in the last couple of years.
- AFX's Operating Margin of 10.03% is in line compared to the rest of the industry. AFX outperforms 47.76% of its industry peers.
- AFX's Operating Margin has declined in the last couple of years.
- The Gross Margin of AFX (52.76%) is comparable to the rest of the industry.
- In the last couple of years the Gross Margin of AFX has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.03% | ||
| PM (TTM) | 6.34% | ||
| GM | 52.76% |
OM growth 3Y-21.67%
OM growth 5Y-5.49%
PM growth 3Y-25.69%
PM growth 5Y-7.11%
GM growth 3Y-3.8%
GM growth 5Y-1.12%
2. Health
2.1 Basic Checks
- AFX has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
- AFX has about the same amout of shares outstanding than it did 1 year ago.
- Compared to 5 years ago, AFX has less shares outstanding
- AFX has a better debt/assets ratio than last year.
2.2 Solvency
- An Altman-Z score of 3.00 indicates that AFX is not in any danger for bankruptcy at the moment.
- AFX has a better Altman-Z score (3.00) than 61.19% of its industry peers.
- The Debt to FCF ratio of AFX is 4.41, which is a neutral value as it means it would take AFX, 4.41 years of fcf income to pay off all of its debts.
- AFX has a Debt to FCF ratio (4.41) which is in line with its industry peers.
- AFX has a Debt/Equity ratio of 0.27. This is a healthy value indicating a solid balance between debt and equity.
- AFX's Debt to Equity ratio of 0.27 is fine compared to the rest of the industry. AFX outperforms 64.18% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.27 | ||
| Debt/FCF | 4.41 | ||
| Altman-Z | 3 |
ROIC/WACC0.85
WACC6.82%
2.3 Liquidity
- A Current Ratio of 2.35 indicates that AFX has no problem at all paying its short term obligations.
- AFX has a better Current ratio (2.35) than 71.64% of its industry peers.
- A Quick Ratio of 1.44 indicates that AFX should not have too much problems paying its short term obligations.
- AFX has a better Quick ratio (1.44) than 74.63% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.35 | ||
| Quick Ratio | 1.44 |
3. Growth
3.1 Past
- AFX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -19.90%.
- Measured over the past 5 years, AFX shows a small growth in Earnings Per Share. The EPS has been growing by 3.28% on average per year.
- The Revenue has been growing slightly by 7.82% in the past year.
- AFX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.78% yearly.
EPS 1Y (TTM)-19.9%
EPS 3Y-21.2%
EPS 5Y3.28%
EPS Q2Q%-14.49%
Revenue 1Y (TTM)7.82%
Revenue growth 3Y5.39%
Revenue growth 5Y10.78%
Sales Q2Q%8.27%
3.2 Future
- The Earnings Per Share is expected to grow by 19.64% on average over the next years. This is quite good.
- AFX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.21% yearly.
EPS Next Y24.48%
EPS Next 2Y22.06%
EPS Next 3Y22.65%
EPS Next 5Y19.64%
Revenue Next Year4.23%
Revenue Next 2Y5.18%
Revenue Next 3Y5.72%
Revenue Next 5Y6.21%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 17.76, which indicates a rather expensive current valuation of AFX.
- Based on the Price/Earnings ratio, AFX is valued cheaper than 85.07% of the companies in the same industry.
- AFX's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.30.
- A Price/Forward Earnings ratio of 14.27 indicates a correct valuation of AFX.
- Based on the Price/Forward Earnings ratio, AFX is valued cheaper than 80.60% of the companies in the same industry.
- Compared to an average S&P500 Price/Forward Earnings ratio of 24.32, AFX is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.76 | ||
| Fwd PE | 14.27 |
4.2 Price Multiples
- AFX's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. AFX is cheaper than 88.06% of the companies in the same industry.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of AFX indicates a rather cheap valuation: AFX is cheaper than 82.09% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.19 | ||
| EV/EBITDA | 8.97 |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- A more expensive valuation may be justified as AFX's earnings are expected to grow with 22.65% in the coming years.
PEG (NY)0.73
PEG (5Y)5.41
EPS Next 2Y22.06%
EPS Next 3Y22.65%
5. Dividend
5.1 Amount
- With a Yearly Dividend Yield of 1.39%, AFX has a reasonable but not impressive dividend return.
- In the last 3 months the price of AFX has falen by -36.02%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
- Compared to an average industry Dividend Yield of 0.95, AFX pays a bit more dividend than its industry peers.
- Compared to the average S&P500 Dividend Yield of 1.82, AFX is paying slightly less dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.39% |
5.2 History
- The dividend of AFX decreases each year by -1.59%.
Dividend Growth(5Y)-1.59%
Div Incr Years1
Div Non Decr Years4
5.3 Sustainability
- AFX pays out 37.19% of its income as dividend. This is a sustainable payout ratio.
DP37.19%
EPS Next 2Y22.06%
EPS Next 3Y22.65%
CARL ZEISS MEDITEC AG - BR / AFX.DE FAQ
What is the fundamental rating for AFX stock?
ChartMill assigns a fundamental rating of 5 / 10 to AFX.DE.
What is the valuation status of CARL ZEISS MEDITEC AG - BR (AFX.DE) stock?
ChartMill assigns a valuation rating of 6 / 10 to CARL ZEISS MEDITEC AG - BR (AFX.DE). This can be considered as Fairly Valued.
Can you provide the profitability details for CARL ZEISS MEDITEC AG - BR?
CARL ZEISS MEDITEC AG - BR (AFX.DE) has a profitability rating of 4 / 10.
What are the PE and PB ratios of CARL ZEISS MEDITEC AG - BR (AFX.DE) stock?
The Price/Earnings (PE) ratio for CARL ZEISS MEDITEC AG - BR (AFX.DE) is 17.76 and the Price/Book (PB) ratio is 1.21.
Is the dividend of CARL ZEISS MEDITEC AG - BR sustainable?
The dividend rating of CARL ZEISS MEDITEC AG - BR (AFX.DE) is 3 / 10 and the dividend payout ratio is 37.19%.